Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8801-8810 Newer>

Chemistry World April 8, 2014 Emma Stoye	Contamination troubles strike GSK Pharma giant GlaxoSmithKline has been warned by the US Food and Drug Administration to address manufacturing problems at the SmithKline Beecham chemical plant in Cork, Ireland, after FDA inspectors found evidence of contamination.
Chemistry World April 7, 2014 Emma Stoye	Lilly wins cancer drug patent dispute Eli Lilly stands to gain billions of dollars in revenue from sales of chemotherapy drug Alimta in the US, after it won a legal battle to uphold a patent covering the drug's use in combination with B vitamins.
Chemistry World April 3, 2014 Emma Stoye	Pharma giants plan new public--private collaborations AstraZeneca will partner with the Medical Research Council, in its new Cambridge site, while the Wellcome Trust Genome Campus will host a new center for target validation studies, jointly founded with the European Bioinformatics Institute and GlaxoSmithKline.
Chemistry World March 31, 2014	Super separators First used in the mid-20th century, high performance liquid chromatography has matured and is now the workhorse of industrial analysis, while the pharmaceutical sector is one of the main customers of HPLC manufacturers.
Chemistry World March 28, 2014 Phillip Broadwith	Baxter aims to divide and conquer US drugmaker Baxter International is spinning off its biopharmaceuticals business to create two independent companies.
Chemistry World March 26, 2014 Phillip Broadwith	AstraZeneca boosts open innovation efforts Astrazeneca has launched a new web portal, bringing together new and existing open innovation programs. The aim is to make collaboration with academics, other companies, governments and non-government organizations easier.
Chemistry World March 26, 2014 Phillip Broadwith	$1.2bn J&J deceptive marketing fine overturned The Arkansas Supreme Court has overturned a lower court's fine of $1.2 billion, imposed on Johnson & Johnson's subsidiary Janssen in April 2012 over its marketing of antipsychotic drug Risperdal (risperidone).
HBS Working Knowledge March 26, 2014 Dina Gerdeman	How Electronic Patient Records Can Slow Doctor Productivity Electronic health records are sweeping through the medical field, but some doctors report a disturbing side effect. Instead of becoming more efficient, some practices are becoming less so. Robert Huckman's research explains why.
Chemistry World March 17, 2014 Phillip Broadwith	US focuses pharma supply chain scrutiny The US Food and Drug Administration has named 13 companies that will be allowed to import drug products into the US with reduced scrutiny.
Chemistry World March 17, 2014 Phillip Broadwith	UK to fast-track access to critical medicines Critically ill patients in the UK could receive new medicines before they are formally approved under a new scheme beginning in April.
<Older 8801-8810 Newer> Return to current articles.